Ionizing radiation suppresses FAP-1 mRNA level in A549 cells via p53 activation

FEBS Letters

Volumn 580, Issue 18, 2006, Pages 4387-4391

  Yamada, Toru ^a   Maruyama, Muneharu ^a   Fujita, Tadashi ^a   Miyabayashi, Koutarou ^a   Shinoda, Chie ^a   Kawagishi, Yukio ^a   Fujishita, Takashi ^a   Hayashi, Ryuji ^a   Miwa, Toshiro ^a   Arai, Nobuki ^a   Matsui, Shoko ^a   Sugiyama, Eiji ^a   Kobayashi, Masashi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Fas; Fas associated phosphatase 1; Ionizing radiation; p53

Indexed keywords

FAS ASSOCIATED PHOSPHATASE 1; MESSENGER RNA; PIFITHRIN ALPHA; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD95; BENZOTHIAZOLES; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; PROTEIN-TYROSINE-PHOSPHATASE; RADIATION, IONIZING; RNA, MESSENGER; THIAZOLES; TOLUENE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33746336984     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.07.003     Document Type: Article

References (23)

1. Zhivotovsky B., Joseph B., and Orrenius S. Tumor radiosensitivity and apoptosis. Exp. Cell Res. 248 (1999) 10-17
2. WILD-TYPE cancer cells treated with ionizing radiation. Int. J. Cancer 73 (1997) 757-762
3. Müller M., Wilder S., Bannasch D., Israeli D., Lehlbach K., Li-Weber M., Friedman S.L., Galle P.R., Stremmel W., Oren M., and Krammer P.H. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med. 188 (1998) 2033-2045
4. Bennett M., Macdonald K., Chan S.-W., Luzio J.P., Simari R., and Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282 (1998) 290-293
5. Sato T., Irie S., Kitada S., and Reed J.C. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268 (1995) 411-415
6. Li Y., Kanki H., Hachiya T., Ohyama T., Irie S., Tang G., Mukai J., and Sato T. Negative regulation of Fas-mediated apoptosis by FAP-1 in human cancer cells. Int. J. Cancer 87 (2000) 473-479
7. Ivanov V.N., Bergami P.L., Maulit G., Sato T., Sassoon D., and Ronai Z. FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface. Mol. Cell. Biol. 23 (2003) 3623-3635
8. Irie S., Li Y., Kanki H., Ohyama T., Deaven L.L., Somlo S., and Sato T. Identification of two Fas-associated phosphatase-1 (FAP-1) promoters in human cancer cells. DNA Seq. 11 (2001) 519-526
9. Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., and Kuroki T. Screening the p53 status of human cell lines using a yeast functional assay. Mol. Carcinog. 19 (1997) 243-253
10. Ungefroren H., Voss M., Jansen M., Roeder C., Henne-Bruns D., Kremer B., and Kalthoff H. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res. 58 (1998) 1741-1749
11. Araya J., Maruyama M., Sassa K., Fujita T., Hayashi R., Matsui S., Kashii T., Yamashita N., Sugiyama E., and Kobayashi M. Ionizing radiation enhances matrix metalloproteinase-2 production in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 280 (2001) L30-L38
12. Ghosh J.C., Izumida Y., Suzuki K., Komada S., and Watanabe M. Dose-dependent biphasic accumulation of TP53 protein in normal human embryo cells after X irradiation. Radiat. Res. 153 (2000) 305-311
13. Nambu Y., Hughes S.J., Rehemtulla A., Hamstra D., Orringer M.B., and Beer D.G. Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas. J. Clin. Invest. 101 (1998) 1102-1110
14. Lee S.H., Shin M.S., Park W.S., Kim S.Y., Kim H.S., Lee J.H., Han S.Y., Lee H.K., Park J.Y., Oh R.R., Jang J.J., Lee J.Y., and Yoo N.J. Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues. APMIS 107 (1999) 1101-1108
15. Lee S.H., Shin M.S., Lee J.Y., Park W.S., Kim S.Y., Jang J.J., Dong S.M., Na E.Y., Kim C.S., Kim S.H., and Yoo N.J. In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas. J. Pathol. 188 (1999) 207-212
16. Meinhold-Heerlein I., Stenner-Liewen F., Liewen H., Kitada S., Krajewska M., Krajewski S., Zapata J.M., Monks A., Scudiero D.A., Bauknecht T., and Reed J.C. Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer. Am. J. Pathol. 158 (2001) 1335-1344
17. Yao H., Song E., Chen J., and Hamar P. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer. Br. J. Cancer 91 (2004) 1718-1725
18. Foehr E.D., Lorente G., Vincent V., Nikolich K., and Urfer R. FAS associated phosphatase (FAP-1) blocks apoptosis of astrocytomas through dephosphorylation of FAS. J. Neuro-Oncol. 74 (2005) 241-248
19. Mishima K., Nariai Y., and Yoshimura Y. Etodolac, a selective cyclo-oxygenase-2 inhibitor, enhances carboplatin-induced apoptosis of human tongue carcinoma cells by down-regulation of FAP-1 expression. Oral. Oncol. 41 (2005) 77-81
20. Corcoran C.A., He Q., Huang Y., and Sheikh M.S. Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis. Oncogene 24 (2005) 1634-1640
21. Song E., Chen J., Antus B., Wang M., Xie Y., Ouyang N., Yao H., and Exton M.S. Interleukin-2 enhances susceptibility of colon cancer cells to FasR-mediated apoptosis by up-regulating Fas receptor level and down-regulating FAP-1 expression. Int. J. Immunopathol. Pharmacol. 13 (2000) 113-122
22. Mundle S.D., Mativi B.Y., Bagai K., Feldman G., Cheema P., Gautam U., Reza S., Cartlidge J.D., Venugopal P., Shetty V., Gregory S.A., Robin E., Rifkin S., Shah R., and Raza A. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows. Int. J. Hematol. 70 (1999) 83-90
23. Abaan O.D., Levenson A., Khan O., Furth P.A., Üren A., and Toretsky J.A. PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's sarcoma tumorigenesis. Oncogene 24 (2005) 2715-2722